A new treatment for prostate cancer developed and trialled in London has been licensed for use.
Enzalutamide was developed by researchers at the Royal Marsden and University College London hospitals.
The one a day pill checks the spread of the cancer.
Reseachers say the most exciting aspect of this new drug is that is has very few side effects- unlike many cancer treatements.
More top news
The 47-year-old man died shortly after 3pm on Tuesday.
Specialist explosive detection dogs searched through the town examining letter boxes and phone booths for signs of potential devices.
Temperatures reached 29.1C in St James's Park, central London.